Cigna Group (NYSE:CI) Given Average Recommendation of “Moderate Buy” by Analysts

Cigna Group (NYSE:CI) has been assigned an average recommendation of “Moderate Buy” from the twenty-two research firms that are presently covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation, seventeen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $333.1053.

A number of brokerages have recently issued reports on CI. Deutsche Bank Aktiengesellschaft raised their price objective on Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research note on Tuesday, February 10th. Mizuho set a $325.00 target price on Cigna Group in a report on Friday, January 9th. Barclays reduced their price target on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research report on Friday, February 6th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cigna Group in a research report on Monday, December 29th. Finally, Royal Bank Of Canada dropped their price objective on Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research note on Friday, February 6th.

Cigna Group Stock Performance

NYSE:CI opened at $262.83 on Friday. The company has a market capitalization of $69.26 billion, a price-to-earnings ratio of 11.85, a PEG ratio of 0.92 and a beta of 0.27. The business has a 50 day moving average of $277.86 and a 200 day moving average of $281.70. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were issued a dividend of $1.56 per share. The ex-dividend date was Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Cigna Group

Large investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its holdings in Cigna Group by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after purchasing an additional 414,834 shares in the last quarter. State Street Corp boosted its stake in Cigna Group by 1.8% in the 4th quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock worth $3,396,132,000 after purchasing an additional 224,122 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in Cigna Group by 8.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock valued at $3,249,113,000 after purchasing an additional 903,334 shares during the last quarter. Dodge & Cox increased its stake in Cigna Group by 19.7% during the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after purchasing an additional 1,833,389 shares in the last quarter. Finally, Sanders Capital LLC raised its holdings in Cigna Group by 0.5% in the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after buying an additional 35,150 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.